FDA Investigator Andrace L Deyampert

Andrace L Deyampert has conducted inspections on 85 sites in 6 countries as of 19 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
85
Last Inspection Date:
19 Jan 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
100003382
Countries of Inspections:
United States of America, Australia, India, Canada, Hungary, Poland
FDA Investigators that have inspected at least one site in common with Andrace L Deyampert:
Alanna L Mussawwir Bias, Alia Legaux, Allen F Hall, Amanda E Lewin, PhD, Amanda J White, Andrea D Swingle, Angela Shepas, Anthony R Petriella, Azza Talaat, Barbara A Rusin, Barbara Janine Breithaupt, Bei Y He, Benjamin J Smith, Byungja E Marciante, Camille D Brown, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, Charles I Ann, Charles L Zhou, Christina Eggleston, Constantin Y Philopoulos, Corrine M Carter, Courtney N Long, Daniel L Aisen, David A Paterson, Debara R Reese, Debara Reese, Denise L Burosh, Dennis E Guilfoyle, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Dr. Gopa Biswas, PhD, Dustin R Abaonza, Elisa M Fleming, Emest F Bizjak, Emily J Orban, Erma Zaimova, Gene R Gunn, Janete F Guardia, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, John A Iwen, Joseph A Piechocki, Joseph R Strelnik, Joy P Matthias, Karen M Montgomery (KMM), Kathleen B Swat, Kathryn G Brown, Kent A Conforti, Kristina Mezin, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren Iacono Connors, PhD, Lauren R Collins, Leigh Anne Myers, Leighton Kn Gai, Lequita M Mayhew, Linda Galindo, Lisa M Bellows, Lisa P Oakes, Luella J Rossi, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Michael Shanks, MS, Michele L Forster, PhD, Mohsen Rajabi Abhari, FDA, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy A Bellamy, Nathan R Moon, Neali H Lucas, Nicola M Fenty Stewart, Owens, Paige E Shelborne, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick D Stone, MS, Patsy J Domingo, Paula J Bretz, Phal K Chhun, Qiao Y Bobo, Rafeeq A Habeeb, Raymond T Oji, Rebecca E Dombrowski, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Saikat I Bhuiyan, Sandra A Boyd, Sanket N Patel, Scott B Laufenberg, Shalonda C Clifford, Shaquenta Y Perkins, Sherri J Jackson, Sripal R Mada, PhD, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan F Laska, MS, Susan P Bruederle, Suyang Qin, Tara K Carmody, Tawny L Colling, Terrance L Thomas, Theressa B Smith, Thomas J Arista, Thomas R Beilke, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tracey L Siebesma, Tracy R Ball, Travis M Beard, Vickie J Kanion, Wayne E Seifert, William D Tingley, Yangmin Ning, Yaw O Osei, Yumi J Hiramine, Yvette E Guillermo

Andrace L Deyampert's Documents

Publish Date Document Type Title
October, 2022 FDA 483 Jeffrey W. Taub, M.D. - Form 483, 2022-10-12
November, 2015 FDA 483 Response Mansoor Qureshi - Form 483R, 2015-11-23
May, 2019 FDA 483 Susan P. King-Harris, D.P.M. - Form 483, 2019-05-09
March, 2016 EIR Opada Alzohaili, M.D. - EIR, 2016-03-29
November, 2015 FDA 483 Mansoor Qureshi - Form 483, 2015-11-09
August, 2015 FDA 483 Response Hurley Medical Center IRB - Form 483R, 2015-09-04
April, 2016 FDA 483 Jay H. Sandberg, D.O. - Form 483, 2016-04-20
September, 2015 FDA 483 Michigan State University IRB - Form 483, 2015-09-02
September, 2021 FDA 483 Sabine S. Hazan, M.D. - Form 483, 2021-09-21
April, 2017 FDA 483 Gregory Yanik, M.D. - Form 483, 2017-04-11
September, 2015 EIR Michigan State University IRB - EIR, 2015-09-02
August, 2015 FDA 483 Hurley Medical Center IRB - Form 483, 2015-08-21
April, 2017 EIR Gregory Yanik, M.D. - EIR, 2017-04-11
October, 2015 FDA 483 Arthur Riba, M.D. - Form 483, 2015-10-15
December, 2014 EIR Arnold S. Monto, M.D. - EIR, 2014-12-11
July, 2020 FDA 483 Samer Kazziha MD - Form 483, 2020-07-31
January, 2019 FDA 483 Bruce G. Redman, D.O. - Form 483, 2019-01-11
July, 2016 FDA 483 Response Berhane nmi Seyoum, M.D. - Form 483R, 2016-07-27
June, 2015 FDA 483 Himanshu J. Patel, M.D. - Form 483, 2015-06-22
June, 2019 EIR Covance Clinical Research Unit, Inc. - EIR, 2019-06-07
April, 2016 FDA 483 Roshni Kulkarni, MD - Form 483, 2016-04-28
April, 2016 EIR Roshni Kulkarni, MD - EIR, 2016-04-28
January, 2022 FDA 483 Donna S. Hrozencik, M.D. - Form 483, 2022-01-26
October, 2016 EIR David E. Haines, M.D. - EIR, 2016-10-06
December, 2014 FDA 483 Arnold S. Monto, M.D. - Form 483, 2014-12-11
October, 2016 FDA 483 Response David E. Haines, M.D. - Form 483R, 2016-10-25
June, 2017 FDA 483 Cooke, David L. M.D. - Form 483, 2017-06-29
July, 2016 EIR Berhane nmi Seyoum, M.D. - EIR, 2016-07-11
July, 2019 FDA 483 James R. Corbett, M.D. - Form 483, 2019-07-08
March, 2016 FDA 483 Opada Alzohaili, M.D. - Form 483, 2016-03-29
July, 2021 FDA 483 John M Wo MD - Form 483, 2021-07-23
June, 2021 FDA 483 Moshe Talpaz, MD - Form 483, 2021-06-17
July, 2016 FDA 483 Berhane nmi Seyoum, M.D. - Form 483, 2016-07-11
October, 2015 EIR Arthur Riba, M.D. - EIR, 2015-10-15
May, 2018 FDA 483 Zoltan Laszlo, M.D. - Form 483, 2018-05-18
October, 2016 FDA 483 David E. Haines, M.D. - Form 483, 2016-10-06
November, 2015 EIR Mansoor Qureshi - EIR, 2015-11-09
January, 2022 EIR Donna S. Hrozencik, M.D. - EIR, 2022-01-26
May, 2019 EIR Susan P. King-Harris, D.P.M. - EIR, 2019-05-09
June, 2019 FDA 483 Covance Clinical Research Unit, Inc. - Form 483, 2019-06-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more